Design and Optimization of a Combined Cooling/Antisolvent Crystallization Process
Source abstract
Abstract
Design and optimization are important steps during the development of crystallization processes. The combined cooling/antisolvent crystallization of acetylsalicylic acid (ASA) in ethanol−water mixtures is studied by means of experiments and population balance modeling. Model-based approaches require accurate kinetics and thermodynamic data, which are obtained in this work using in situ process monitoring techniques such as attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy and focused beam reflectance measurement (FBRM). Solubility is measured in situ as a function of temperature and solvent composition using a multivariate calibration model for the ATR-FTIR. Nucleation and growth kinetics are determined based on crystallization experiments by a combination of a population balance model and an integral parameter estimation technique. The model is finally used to calculate optimal cooling and antisolvent addition profiles of the combined cooling/antisolvent crystallization process using a multiobjective optimization approach which optimizes the process with respect to product properties, that is, particle size distribution, and performance, that is, process time. It was found that the solubility exhibits a maximum at 17 wt% water and that the growth rate correlates well with the solubility. No effect of the solvent composition on the nucleation rate could be identified. The optimized trajectories for cooling and antisolvent could greatly reduce the number of nuclei formed as shown through modeling and experiments. The study shows that combining cooling and antisolvent crystallization allows both improving productivity and reducing the formation of fines, and illustrates how process analytical tools and population balance modeling also are effective in crystallization processes where temperature and solvent composition change.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Crystallization and Solubility Studies · Analytical Chemistry and Chromatography · Process Optimization and Integration
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Process Engineering, ETH Zurich, CH-8092 Zurich, Switzerland
Pharmaceutical & Analytical Development, Novartis Pharma AG, CH-4056 Basel, Switzerland
References (47)
Show source-provided references
1. FDA, U.S. Food and Drug Administration. Guidance for Industry: PAT— A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance, 2004, http://www.fda.gov/cder/guidance/6419fnl.pdf.
2. Schöll J. · Faraday Discuss. · 2007 · 136 · 23810.1039/b616285a ↗
3. Dunuwila D. D. · J. Cryst. Growth · 1994 · 137 · 56110.1016/0022-0248(94)90999-7 ↗
4. Cornel J. · Ind. Eng. Chem. Res. · 2008 · 47 · 487010.1021/ie800236v ↗
5. Lewiner F. · Chem. Eng. Sci. · 2001 · 56 · 206910.1016/S0009-2509(00)00508-X ↗
6. Groen H. · J. Phys. Chem. B · 2001 · 105 · 1072310.1021/jp011128l ↗
7. Borissova A. · Cryst. Growth Des. · 2004 · 4 · 105310.1021/cg049947t ↗
8. Schöll J. · Cryst. Growth Des. · 2007 · 7 · 165310.1021/cg0700869 ↗
9. Sparks R. G. · Part. Part. Syst. Charact. · 1993 · 10 · 27910.1002/ppsc.19930100512 ↗
10. Tadayyon A. · Part. Part. Syst. Charact. · 1998 · 15 · 12710.1002/(SICI)1521-4117(199817)15:3<127::AID-PPSC127>3.0.CO;2-B ↗
11. Barrett P. · Part. Part. Syst. Charact. · 1999 · 16 · 20710.1002/(SICI)1521-4117(199910)16:5<207::AID-PPSC207>3.0.CO;2-U ↗
12. Chew J. W. · Cryst. Growth Des. · 2007 · 7 · 141610.1021/cg060822t ↗
13. Shaikh A. A. · Ind. Eng. Chem. Res. · 2005 · 44 · 992110.1021/ie0505211 ↗
14. Monnier O. · Chem. Eng. Sci. · 1997 · 52 · 112510.1016/S0009-2509(96)00482-4 ↗
15. Li M. Z. · Chem. Eng. Sci. · 2005 · 60 · 325110.1016/j.ces.2005.01.008 ↗
16. Worlitschek J. · Part. Part. Syst. Charact. · 2005 · 22 · 8110.1002/ppsc.200400872 ↗
17. Kempkes M. · Chem. Eng. Sci. · 2008 · 63 · 551310.1016/j.ces.2008.08.007 ↗
18. Schöll J. · Chem. Eng. Technol. · 2006 · 29 · 25710.1002/ceat.200500369 ↗
19. Barrett P. · Chem. Eng. Res. Des. · 2002 · 80 · 79910.1205/026387602320776876 ↗
20. Zhou G. X. · Cryst. Growth Des. · 2006 · 6 · 89210.1021/cg0504049 ↗
21. Trifkovic M. · Ind. Eng. Chem. Res. · 2008 · 47 · 158610.1021/ie071125g ↗
22. Sarkar D. · Chem. Eng. Sci. · 2006 · 61 · 528210.1016/j.ces.2006.03.055 ↗
23. Sarkar D. · Aiche J. · 2007 · 53 · 116410.1002/aic.11142 ↗
24. Worlitschek J. · Cryst. Growth Des. · 2004 · 4 · 89110.1021/cg034179b ↗
25. Nowee S. M. · Cryst. Growth Des. · 2008 · 8 · 269810.1021/cg700720t ↗
26. Miller S. M. · Aiche J. · 1994 · 40 · 131210.1002/aic.690400805 ↗
27. Fujiwara M. · J. Process Control · 2005 · 15 · 49310.1016/j.jprocont.2004.08.003 ↗
28. Nagy Z. K. · J. Process Control · 2008 · 18 · 39910.1016/j.jprocont.2007.10.006 ↗
29. Garside J. · 2002
30. Granberg R. A. · J. Cryst. Growth · 1999 · 199 · 128710.1016/S0022-0248(98)01013-6 ↗
31. Granberg R. A. · Chem. Eng. Sci. · 2001 · 56 · 230510.1016/S0009-2509(00)00439-5 ↗
32. Nagy Z. K. · J. Process Control · 2008 · 18 · 85610.1016/j.jprocont.2008.06.002 ↗
33. O’Grady D. · Chem. Eng. Res. Des. · 2007 · 85 · 94510.1205/cherd06207 ↗
34. Vishweshwar P. · J. Am. Chem. Soc. · 2005 · 127 · 1680210.1021/ja056455b ↗
35. Randolph A. · 1988
36. Kumar S. · Chem. Eng. Sci. · 1997 · 52 · 465910.1016/S0009-2509(97)00307-2 ↗
37. Togkalidou T. · J. Cryst. Growth · 2001 · 231 · 53410.1016/S0022-0248(01)01518-4 ↗
38. Geladi P. · Anal. Chim. Acta · 1986 · 185 · 110.1016/0003-2670(86)80028-9 ↗
39. Nadler B. · J. Chemom. · 2005 · 19 · 4510.1002/cem.906 ↗
40. Shao J. · J. Am. Stat. Assoc. · 1993 · 88 · 48610.1080/01621459.1993.10476299 ↗
41. Togkalidou T. · Org. Process Res. Dev. · 2002 · 6 · 31710.1021/op015516x ↗
42. Rawlings J. B. · Ind. Eng. Chem. Res. · 1993 · 32 · 127510.1021/ie00019a002 ↗
43. Beck J. V. · 1977
44. Mersmann A. · 200110.1201/9780203908280 ↗
45. Cornel, J.; Lindenberg, C.; Mazzotti, M.,Experimental characterization and population balance modeling of the polymorph transformation ofl-glutamic acid,submitted to Cryst. Growth Des2008, in press.10.1021/cg800387a ↗
46. Mersmann A. · J. Cryst. Growth · 1990 · 102 · 84110.1016/0022-0248(90)90850-K ↗
47. Deb K. · 2001